Riskpilot← Back to searchSign inGet full accessLHLS INTERNASJONALE TUBERKULOSESTIFTELSE
STIActiveOrg 999281931Schweigaards gate 34A, 0191 OsloActivities of other membership organisations n.e.c. · NACE 9499Est. 20128 employeeswww.lhl-internasjonal.no
Revenue 2024
NOK 29,1M
-10% vs 2023
EBITDA margin
3.4%
+191% vs 2023
Equity ratio
79.0%
Financial strength
Net profit 2024
NOK 981K
+191% vs 2023
| Revenue | NOK 29,1M | -10% |
| EBITDA | NOK 981K | +191% |
| Net profit | NOK 981K | +191% |
| Total assets | NOK 22,3M | +3% |
| Equity | NOK 17,6M | +6% |
| Employees | 8 | — |
Legal name
LHLS INTERNASJONALE TUBERKULOSESTIFTELSE
Org number
999281931
Legal form
Stiftelse
NACE code
9499 · Activities of other membership organisations n.e.c.
Founded
10. oktober 2012
Share capital
—
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Schweigaards gate 34A, 0191 Oslo
Phone
+4722799222
Email
post@lhl-internasjonal.no
Website
www.lhl-internasjonal.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 26 092 | 27 116 | 31 787 | 37 040 | 37 698 | 32 488 | 29 091 |
| Staff expenses | −11 231 | −5 740 | −6 116 | −6 104 | −6 526 | −0 | −6 881 |
| EBITDA | −796 | 292 | 323 | 1 594 | 1 164 | 337 | 981 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −796 | 292 | 323 | 1 594 | 1 164 | 337 | 981 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −796 | 292 | 323 | 1 594 | 1 164 | 337 | 981 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −796 | 292 | 323 | 1 594 | 1 164 | 337 | 981 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 14 645 | 18 667 | 23 728 | 25 333 | 22 701 | 21 594 | 22 294 |
| Equity | 12 927 | 13 219 | 13 542 | 15 136 | 16 301 | 16 638 | 17 619 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 718 | 5 448 | 10 186 | 10 197 | 6 401 | 4 956 | 4 675 |
| Total debt | 1 718 | 5 448 | 10 186 | 10 197 | 6 401 | 4 956 | 4 675 |
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
20182024
Equity ratio
79.0%
This company
38.2%
Market median
+107% vs market
20182024
Return on equity
5.6%
This company
18.4%
Market median
-70% vs market
20182024
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
20182024
Asset turnover
1.30×
This company
1.12×
Market median
+16% vs market
20182024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MD Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LHLS INTERNASJONALE TUBERKULOSESTIFTELSE also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mona Drage | Chief Executive Officer | 0 companies |
| Laila Iren Løchting | Board of Directors | 0 companies |
| Arne-Ketil Hafstad | Board of Directors | 0 companies |
| Frode Jahren | Chairman | 0 companies |
| Berthe Galdal Stenberg | Board of Directors | 0 companies |
| Ingrid Skjennum | Board of Directors | 0 companies |
| Arnulf Torbjørnsen | Board of Directors | 0 companies |
| Bernt Gudmund Apeland | Chairman | 0 companies |
| Chi Ching Vivian Lam | Board of Directors | 0 companies |
| Mari Larsen | Chairman | 0 companies |